Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/01/2855130/0/en/aTyr-Pharma-to-Participate-in-April-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/03/14/2846669/0/en/aTyr-Pharma-Announces-Fourth-Quarter-and-Full-Year-2023-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/28/2836889/0/en/aTyr-Pharma-to-Webcast-Conference-Call-Reporting-Fourth-Quarter-and-Full-Year-End-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/21/2832714/0/en/aTyr-Pharma-Announces-Expanded-Access-Program-EAP-for-EFZO-FIT-Clinical-Trial-Participants.html
https://www.globenewswire.com/news-release/2024/01/29/2818867/0/en/aTyr-Pharma-to-Present-Posters-Highlighting-Importance-of-Neuropilin-2-in-Immune-Regulation-at-Keystone-Symposia-on-Myeloid-Cell-Diversity.html
https://www.globenewswire.com//news-release/2024/01/18/2811479/0/en/aTyr-Pharma-Announces-Howard-University-President-Emeritus-Dr-Wayne-A-I-Frederick-as-Advisor.html
https://www.globenewswire.com//news-release/2023/11/13/2778983/0/en/aTyr-Pharma-Presents-Poster-Demonstrating-Preclinical-Effects-of-Efzofitimod-in-Rheumatoid-Arthritis-and-Rheumatoid-Arthritis-Associated-ILD-at-the-ACR-Convergence-2023.html
https://www.globenewswire.com//news-release/2023/11/09/2777759/0/en/aTyr-Pharma-Announces-Third-Quarter-2023-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2023/11/01/2771081/0/en/aTyr-Pharma-to-Present-at-November-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/10/31/2770137/0/en/aTyr-Pharma-Announces-Dosing-of-First-Patient-in-Phase-2-EFZO-CONNECT-Study-of-Efzofitimod-in-Patients-with-SSc-ILD.html